Increased CAP37 Expression in Stable Chronic Obstructive Pulmonary Disease

Abstract

Objective

Cationic antimicrobial protein of 37 kDa (CAP37), a neutrophil-derived protein originally identified for its antimicrobial activity, is now known to have many regulatory effects on host cells. However, its role in the pathogenesis of chronic obstructive pulmonary disease (COPD) has not been studied. We therefore investigated the expression of CAP37 in COPD and its effects on airway structural cells, including bronchial epithelial cells, smooth muscle cells, and fibroblasts.

Methods

CAP37 was detected in the lung tissue, sputum, and plasma of COPD patients and the control subjects, as well as in the neutrophils stimulated by cigarette smoke extract (CSE). BEAS-2B cells, human bronchial smooth muscle cells (HBSMCs), and MRC-5 cells were treated with CAP37 or an anti-CAP37 antibody plus CAP37. Interleukin (IL)-6 and IL-8 were detected in the BEAS-2B cells. The cell proliferation was analyzed in the HBSMCs. Collagens were also detected in the MRC-5 cells.

Results

The expression of CAP37 was increased in the lung tissue and sputum supernatant of the COPD patients compared with the control subjects. The sputum supernatant CAP37 levels were inversely correlated with the forced expiratory volume in the first second percentage predicted in COPD. CAP37 was induced by CSE stimulation in the peripheral blood neutrophils from healthy non-smokers. CAP37 induced expression of IL-6 and IL-8 in BEAS-2B cells, and collagen expression of lung fibroblasts (MRC-5 cells). However, CAP37 did not significantly alter the proliferation of the HBSMCs.

Conclusion

Our findings indicated that neutrophil-derived CAP37 may be involved in airway inflammation and fibrosis in COPD via affecting the bronchial epithelial cells, and fibroblasts, thus suggesting a possible role of CAP37 in the development and progression of COPD.

Keywords

cationic antimicrobial protein of 37 kDa / chronic obstructive pulmonary disease / fibrosis / inflammation / neutrophil

References

[1] VogelmeierCF, CrinerGJ, MartinezFJ, et al.. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med, 2017, 195(5): 557-582

[2] BarnesPJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol, 2016, 138(1): 16-27

[3] HoggJC, TimensW. The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol, 2009, 4: 435-459

[4] AgustíA, HoggJC. Update on the Pathogenesis of Chronic Obstructive Pulmonary Disease. N Engl J Med, 2019, 381(13): 1248-1256

[5] O’DonnellR, BreenD, WilsonS, et al.. Inflammatory cells in the airways in COPD. Thorax, 2006, 61(5): 448-454

[6] BaraldoS, TuratoG, BadinC, et al.. Neutrophilic infiltration within the airway smooth muscle in patients with COPD. Thorax, 2004, 59(4): 308-312

[7] SiddiquiS, HollinsF, SahaS, et al.. Inflammatory cell microlocalisation and airway dysfunction: cause and effect. Eur Respir J, 2007, 30(6): 1043-1056

[8] ShaferWM, MartinLE, SpitznagelJK. Cationic antimicrobial proteins isolated from human neutrophil granulocytes in the presence of diisopropyl fluorophosphate. Infect Immun, 1984, 45(1): 29-35

[9] TapperH, KarlssonA, MörgelinM, et al.. Secretion of heparin-binding protein from human neutrophils is determined by its localization in azurophilic granules and secretory vesicles. Blood, 2002, 99(5): 1785-1793

[10] FisherJ, LinderA. Heparin-binding protein: a key player in the pathophysiology of organ dysfunction in sepsis. J Intern Med, 2017, 281(6): 562-574

[11] YangY, LiuG, HeQ, et al.. A Promising Candidate: Heparin-Binding Protein Steps onto the Stage of Sepsis Prediction. J Immunol Res, 2019, 2019: 7515346

[12] FisherJ, RussellJA, BentzerP, et al.. Heparin-Binding Protein (HBP): A Causative Marker and Potential Target for Heparin Treatment of Human Sepsis-Induced Acute Kidney Injury. Shock, 2017, 48(3): 313-320

[13] GriffithGL, RussellRA, Kasus-JacobiA, et al.. CAP37 activation of PKC promotes human corneal epithelial cell chemotaxis. Invest Ophthalmol Vis Sci, 2013, 54(10): 6712-6723

[14] OstergaardE, FlodgaardH. A neutrophil-derived proteolytic inactive elastase homologue (hHBP) mediates reversible contraction of fibroblasts and endothelial cell monolayers and stimulates monocyte survival and thrombospondin secretion. J Leukoc Biol, 1992, 51(4): 316-323

[15] GonzalezML, RuanX, KumarP, et al.. Functional modulation of smooth muscle cells by the inflammatory mediator CAP37. Microvasc Res, 2004, 67(2): 168-181

[16] LeeTD, GonzalezML, KumarP, et al.. CAP37, a novel inflammatory mediator: its expression in endothelial cells and localization to atherosclerotic lesions. Am J Pathol, 2002, 160(3): 841-848

[17] BrockAJ, Kasus-JacobiA, LernerM, et al.. The antimicrobial protein, CAP37, is upregulated in pyramidal neurons during Alzheimer’s disease. Histochem Cell Biol, 2015, 144(4): 293-308

[18] PereiraHA, RuanX, KumarP. Activation of microglia: a neuroinflammatory role for CAP37. Glia, 2003, 41(1): 64-72

[19] PellegrinoR, ViegiG, BrusascoV, et al.. Interpretative strategies for lung function tests. Eur Respir J, 2005, 26(5): 948-968

[20] RutgersSR, TimensW, KaufmannHF, et al.. Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD. Eur Respir J, 2000, 15(1): 109-115

[21] HovoldG, PalmcrantzV, KahnF, et al.. Heparin-binding protein in sputum as a marker of pulmonary inflammation, lung function, and bacterial load in children with cystic fibrosis. BMC Pulm Med, 2018, 18(1): 104

[22] WangJ, LiQ, XieJ, et al.. Cigarette smoke inhibits BAFF expression and mucosal immunoglobulin A responses in the lung during influenza virus infection. Respir Res, 2015, 16(1): 37

[23] WangM, GaoP, WuX, et al.. Impaired anti-inflammatory action of glucocorticoid in neutrophil from patients with steroid-resistant asthma. Respir Res, 2016, 17(1): 153

[24] ZhengM, HongW, GaoM, et al.. Long Noncoding RNA COPDA1 Promotes Airway Smooth Muscle Cell Proliferation in Chronic Obstructive Pulmonary Disease. Am J Respir Cell Mol Biol, 2019, 61(5): 584-596

[25] McDonoughJE, YuanR, SuzukiM, et al.. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med, 2011, 365(17): 1567-1575

[26] WangY, JiaM, YanX, et al.. Increased neutrophil gelatinase-associated lipocalin (NGAL) promotes airway remodelling in chronic obstructive pulmonary disease. Clin Sci (Lond), 2017, 131(11): 1147-1159

[27] FahyJV, DickeyBF. Airway mucus function and dysfunction. N Engl J Med, 2010, 363(23): 2233-2247

[28] SoehnleinO. Direct and alternative antimicrobial mechanisms of neutrophil-derived granule proteins. J Mol Med (Berl), 2009, 87(12): 1157-1164

[29] BrusselleGG, JoosGF, BrackeKR. New insights into the immunology of chronic obstructive pulmonary disease. Lancet, 2011, 378(9795): 1015-1026

[30] GaoW, LiL, WangY, et al.. Bronchial epithelial cells: The key effector cells in the pathogenesis of chronic obstructive pulmonary disease. Respirology, 2015, 20(5): 722-729

[31] ChenL, GeQ, TjinG, et al.. Effects of cigarette smoke extract on human airway smooth muscle cells in COPD. Eur Respir J, 2014, 44(3): 634-646

[32] LaiT, WuD, ChenM, et al.. YKL-40 expression in chronic obstructive pulmonary disease: relation to acute exacerbations and airway remodeling. Respir Res, 2016, 17: 31